BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23060481)

  • 1. Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.
    Ormseth MJ; Swift LL; Fazio S; Linton MF; Raggi P; Solus JF; Oeser A; Bian A; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2013 Jan; 22(1):26-33. PubMed ID: 23060481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis.
    Ormseth MJ; Swift LL; Fazio S; Linton MF; Chung CP; Raggi P; Rho YH; Solus J; Oeser A; Bian A; Gebretsadik T; Shintani A; Stein CM
    Atherosclerosis; 2011 Dec; 219(2):869-74. PubMed ID: 21974844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
    Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM
    Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.
    Baker JF; Morales M; Qatanani M; Cucchiara A; Nackos E; Lazar MA; Teff K; von Feldt JM
    J Rheumatol; 2011 Nov; 38(11):2369-75. PubMed ID: 21885493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
    Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.
    Lertnawapan R; Bian A; Rho YH; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Lupus; 2012 Mar; 21(3):279-87. PubMed ID: 22072023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome Components: Shiga Epidemiological Study of Subclinical Atherosclerosis.
    Yamazoe M; Hisamatsu T; Miura K; Kadowaki S; Zaid M; Kadota A; Torii S; Miyazawa I; Fujiyoshi A; Arima H; Sekikawa A; Maegawa H; Horie M; Ueshima H;
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1703-8. PubMed ID: 27283744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.
    Rho YH; Chung CP; Oeser A; Solus J; Raggi P; Gebretsadik T; Shintani A; Stein CM
    J Rheumatol; 2008 Sep; 35(9):1789-94. PubMed ID: 18634156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Solus JF; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2010 May; 62(5):1259-64. PubMed ID: 20213808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
    Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
    Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial adipose tissue is increased in patients with systemic lupus erythematosus.
    Lipson A; Alexopoulos N; Hartlage GR; Arepalli C; Oeser A; Bian A; Gebretsadik T; Shintani A; Stillman AE; Stein CM; Raggi P
    Atherosclerosis; 2012 Aug; 223(2):389-93. PubMed ID: 22770992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus.
    El Magadmi M; Ahmad Y; Turkie W; Yates AP; Sheikh N; Bernstein RM; Durrington PN; Laing I; Bruce IN
    J Rheumatol; 2006 Jan; 33(1):50-6. PubMed ID: 16395749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever.
    Shin TH; Kim HA; Jung JY; Baek WY; Lee HS; Park HJ; Min J; Paik MJ; Lee G; Suh CH
    Metabolomics; 2017 Dec; 14(1):14. PubMed ID: 30830319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis.
    Kao AH; Wasko MC; Krishnaswami S; Wagner J; Edmundowicz D; Shaw P; Cunningham AL; Danchenko N; Sutton-Tyrrell K; Tracy RP; Kuller LH; Manzi S
    Am J Cardiol; 2008 Sep; 102(6):755-60. PubMed ID: 18774002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Asanuma Y; Chung CP; Oeser A; Shintani A; Stanley E; Raggi P; Stein CM
    J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.
    Wigren M; Svenungsson E; Mattisson IY; Gustafsson JT; Gunnarsson I; Zickert A; Elvin K; Jensen-Urstad K; Bengtsson A; Gullstrand B; Fredrikson GN; Nilsson J
    Atherosclerosis; 2018 Mar; 270():1-7. PubMed ID: 29407876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.